Moreover, different factors during cancer growth, such as decreases in glucose-derived citrate, defective OGDH complexes, and isocitrate dehydrogenase, great glutamine demand, and the glutaminolysis process, support the reductive glutamine metabolism. This evidence concerns the gene OGDH and cancer.